Evidence map›Paper›PMID 29712996›Full record

ArticleScientific reports2018

Properties of the ternary complex formed by yeast eIF4E, p20 and mRNA.

Nick Arndt, Daniela Ross-Kaschitza, Artyom Kojukhov, Anton A Komar, Michael Altmann

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Med9 Is a Novel eIF4E-Interacting Protein inInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. eIF4E and Interactors from Unicellular Eukaryotes.International journal of molecular sciences · 2020
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nick ArndtInstitut für Biochemie und Molekulare Medizin, Bühlstr. 28, 3012, Bern, Switzerland.
Daniela Ross-KaschitzaInstitut für Biochemie und Molekulare Medizin, Bühlstr. 28, 3012, Bern, Switzerland.
Artyom KojukhovCenter for Gene Regulation in Health and Disease and Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, OH, 44115, USA.
Anton A KomarCenter for Gene Regulation in Health and Disease and Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, OH, 44115, USA.
Michael AltmannInstitut für Biochemie und Molekulare Medizin, Bühlstr. 28, 3012, Bern, Switzerland. michael.altmann@ibmm.unibe.ch.
Cleveland State University · US

Funding

Understanding the impact of disease causing mutations in FIXR15HL121779 · NHLBI · CLEVELAND STATE UNIVERSITY · PI KOMAR, ANTON A. · 2014 to 2014
$437k
NHLBI NIH HHS R15 HL121779
6 · The paper itself

Abstract

Yeast p20 is a small, acidic protein that binds eIF4E, the cap-binding protein. It has been proposed to affect mRNA translation and degradation, however p20's function as an eIF4E-binding protein (4E-BP) and its physiological significance has not been clearly established. In this paper we present data demonstrating that p20 is capable of binding directly to mRNA due to electrostatic interaction of a stretch of arginine and histidine residues in the protein with negatively charged phosphates in the mRNA backbone. This interaction contributes to formation of a ternary eIF4E/p20/capped mRNA complex that is more stable than complexes composed of capped mRNA bound to eIF4E in the absence of p20. eIF4E/p20 complex was found to have a more pronounced stimulatory effect on capped mRNA translation than purified eIF4E alone. Addition of peptides containing the eIF4E-binding domains present in p20 (motif  YTIDELF), in eIF4G (motif  YGPTFLL) or Eap1 (motif  YSMNELY) completely inhibited eIF4E-dependent capped mRNA translation (in vitro), but had a greatly reduced inhibitory effect when eIF4E/p20 complex was present. We propose that the eIF4E/p20/mRNA complex serves as a stable depository of mRNAs existing in a dynamic equilibrium with other complexes such as eIF4E/eIF4G (required for translation) and eIF4E/Eap1 (required for mRNA degradation).

Indexed as

Amino Acid SequenceArginineBinding SitesEukaryotic Initiation Factor-4EHistidineNuclear Cap-Binding Protein ComplexNucleotide MotifsProtein BindingRNA, MessengerRNA StabilitySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTernary Complex FactorsArginineCBC2 protein, S cerevisiaeEukaryotic Initiation Factor-4EHistidineNuclear Cap-Binding Protein ComplexRNA, MessengerSaccharomyces cerevisiae ProteinsTernary Complex Factors

Identifiers

PMID29712996
PMCPMC5928113
OpenAlexW2805126351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.